matography, and gel filtration on AcA 44, and was heat aggregated as follows: IgG (1 .7 mg/ml) was heated at 55°C for 20 min and centrifuged at 2,000 g for 10 min to remove large aggregates . The supernatant was used at a concentration of 50-100 wg/ml to assess expression of surface receptors for IgG by transfected cells . Human myeloma IgA (Cappell Laboratories, Malvern, PA) containing both monomeric and dimeric IgA was used as an isotype control . The second-stage reagents in the procedure were FITC-labeled F(ab')2 fragments of goat anti-human IgG and IgA (Tago Inc., Burlingame, CA) or goat antimouse IgM (Zymed Laboratories, San Francisco, CA) .
Transiently transfected cells were also examined for ability to bind anti-FcYR mAbs. Culture supernatants of hybridomas producing IV .3 (anti-FcyRII), 32 (anti-FcYRI), and 3G8 (anti-Fc7Rlo) were centrifuged at 12,000 rpm for 10 min before staining . Leu-1 lb was used at 10 ug/ml. Second-stage reagent was FITC-labeled F(ab') 2 fragments of goat anti-mouse IgG and IgM (Jackson Immunoresearch Laboratories, Avondale, PA).
All staining reagents were diluted in HBSS + 10% FCS + 10 mM Hepes buffer . Stained cells were mounted in a solution containing 2% N-propyl-gallate in 90% glycerol/10% PBS, pH 8.45 .
RNA and DNA Blot Analysis . Human placental genomic DNA was isolated as described (30) . For RNA blot analysis, 4,ug/lane of poly(A)+ RNA was subjected to electrophoresis in a formaldehyde/1% agarose gel . The RNA was transferred to a Gene-Screen Plus membrane, baked at 80°C for 2 h, and prehybridized in 50% formamide, 1 .0 M NaCl, 5X Denhardt's solution, 1 % SDS, and 100,ug/ml denatured salmon sperm DNA for 6 h at 42°C. For genomic DNA blot analysis, genomic DNA was digested to completion with the indicated restriction endonuclease and 5 Ag of each digest was electrophoresed on a 1 % agarose gel . DNA was transferred to Gene Screen Plus, dried, and prehybridized as described above . Both filters were hybridized to a s2P-labeled Xho I fragment encoding the entire human FcyRII cDNA in a solution containing 50% formamide, 1 M NaCl, 1 % SDS, IX Denhardt's solution, and 100 wg/ml denatured salmon sperm DNA at 42°C. Filters were washed twice in 2X SSC, 1% SDS at 65°C for 30 min, then washed in 0 .2X SSC, 0.1 % SDS for 30 min at 30'C, and exposed for 18-100 h on Kodak XAR film with an intensifying screen at 90'C .
Generation of Antipeptide Antibodies by In Vitro Immunization . Peptides were synthesized on an Applied Biosystems, Inc ., (Foster City, CA) 430A peptide synthesizer, cleaved with hydrogen fluoride, and purified by preparative HPLC on a Waters Delta Prep system . Peptide identity was confirmed by amino acid analysis. Single cell suspensions from naive BALB/c mouse spleens were immunized in vitro (Vaux, D. J. T., and I . Mellman, unpublished observations). Briefly, spleen cells were resuspended at 2 X 10' cells/ml in medium consisting of aMEM with 1 mM sodium pyruvate, 2 mM glutamine, 50 JUM 2-ME, and 20% heat-inactivated FCS . Lyophilized peptides were resuspended in an equal volume of the above medium, which had been conditioned by mixed mouse thymocytes and sterilized by filtration, Antigen and cells were mixed and cultured at 37°C, 5% C02 in 75-cm2 flasks for 5 d (18 ug/ml antigen). Nonadherent cells were collected, erythrocytes removed, and the remaining spleen cells fused with the SP-2 myeloma at spleen/myeloma ratio of 2:1 using 47% PEG 1500 (J. T. Baker Chemical Co., Phillipsburg, NJ) with 7.5% DMSO. The fused cells were plated in medium containing hypoxanthine and azaserine on a feeder layer of BALB/c mouse peritoneal exudate cells . Wells were fed on days 2, 4, and 6, and screening commenced on day 7 .
Positive wells were identified by solid-phase ELISA . U937 cell lysates (10' cells/ml in PBS containing I% NP-40, 2 mM EDTA, and 0 .22 U/ml aprotinin) were centrifuged at 1,800 g for 10 min to remove nuclei and were incubated overnight at 4'C in Immunolon plates at 30 ,al/well . Wells were washed twice in PBS and blocked with PBS containing 8% goat serum for 2 h at 4°C. Candidate mAb supernatants were incubated in the coated wells for 1 h at 4'C and the plates were washed five times with PBS before a second PBS/8% goat serum blocking step. The second-stage reagent was goat anti-mouse IgG/IgM conjugated to alkaline phosphatase (Zymed Laboratories), 1 :500 in PBS/8% goat serum . After a 1-h incubation, plates were washed five times with PBS, once with 50 mM sodium glycinate, pH 9.8, and developed with a Nitroblue tetrazolium/5-bromo-4-CONA clone 162 (human) FIGURE 1 . chloro-3-indolyl phosphate substrate at pH 9 .8 . Positive wells were expanded and the cells cloned twice in soft agar . Binding in the first screen was confirmed by indirect immunofluorescence and FACS analysis using live U937 cells . All mAbs were of the IgM subclass and showed no reactivity above background on HeLa or HepG2 human cell lines . Preparation of Polyclonal Antipeptide Antisera. Polyclonal antipeptide antisera were raised in rabbits using a popliteal lymph node immunization protocol (31) . Aqueous solutions of unconjugated peptides (2 mg/ml) were emulsified in an equal volume of CFA and a total of 200 tag of peptide was injected into the popliteal lymph nodes of unprimed rabbits. At 4 wk rabbits were boosted subcutaneously with 200 tlg of peptide in IFA . 1 wk later an intravenous boost of 200 Ag unconjugated peptide was given and blood was collected 10 d after the final boost.
Fluorescence Analysis of U937 and Daudi Cells. Both cell lines were maintained in RPM 1 1640 supplemented with 10% FCS, L-glutamine, penicillin-streptomycin, and 50 AM 2-ME (Daudi onl . Cells from logarithmically growing cultures were washed twice in HBSS containing 10 ;o' FCS and 10 mM Hepes buffer, and resuspended at 10 6 cells/ml in HBSS/FCS/Hepes before staining. All staining was performed on ice in glass tubes using 106 cells for each sample . Supernatant-containing IV .3 was used at a final dilution of 1 :80 in HBSS/FCS/Hepes. The isotype control for IV .3 was MOPC 195 ( ,y2brc) at 10 Ag/ml . All washes were done with HBSS/FCS/Hepes . Second-stage reagents were as described above . Cells were analyzed using a FACS II or FACS IV (Becton Dickinson & Co ., Mountain View, CA).
Results
Human FcyR cDNA Clones Homologous to a Mouse Fc[y2b(y]JR cDNA . The human monocyte cell line U937 expresses at least two of the classes of human FcyR (FcyRI and FcyRII ; reference 16) . We constructed a cDNA library from U937 poly(A) + RNA in the mammalian cell expression vector pcD (27) .^-10 5 clones were screened using a 32 P-labeled 800-bp restriction fragment from the 5' end of a mouse FcyR cDNA clone (Fig . 1 and a putative amino acid sequence was deduced. The cDNA clone encodes a protein of 324 amino acids (36 kD) with a structure very similar to that described for the mouse Fc[,y2b/y l ]R . The NH2-terminus contains a hydrophobic signal sequence of up to 30 amino acids, with three possible AUG initiation codons . This region is followed by a predicted extracellular domain of^" 180 amino acids, which, as described for the mouse protein (25, 26) , contains two tandem homology units exhibiting significant sequence homology to members of the Ig gene superfamily . The repeating units are defined by pairs of cysteine residues that are surrounded by sequences characteristic of Ig variable regions (32) . However, like the mouse FcyR and neural cell adhesion molecule (N-CAM) sequences (25) , the number of amino acids between each pair of cysteine residues is too small to account for the typical variable region folding pattern. A comparison of the translated human sequence (Fig. 2) to the National Biomedical Research Foundation protein sequence data base using the program IFIND (Intelligenetics, Inc., Mountain View, CA) revealed a number of significant homologies to Ig-like molecules, including the epithelial cell receptor for polymeric IgA/IgM (poly-IgR; reference 33), the receptor for platelet-derived growth factor, neural cell adhesion molecule (N-CAM), and several proteins encoded by various mouse MHC and human HLA loci.
Using the ALIGN program (34) in conjunction with an Ig family sequence data base (kindly made available by A. F. Williams, MRC Laboratory, Oxford, United Kingdom), a particularly strong homology was found between both Iglike domains of the human FcyR and amino acids 22-195 of the human CSF-1 receptor/c fms proto-oncogene (35), a plasma membrane protein also typical of cells of the mononuclear phagocyte lineage. The best match yielded a highly significant alignment score of 7 .32 SD units (32, 34 ; Fig. 3) .
The extracellular domain is followed by a long and markedly hydrophobic stretch that probably represents the receptor's membrane-spanning segment. By analogy to the more extensively studied mouse FcyR, we presume that this transmembrane domain is about 29 amino acids long (overlined, Fig. 2 ). We note that this region is preceded by 13 amino acids (nucleotides 617-655) that are not markedly hydrophilic.
The extracellular domain contains two potential sites for N-linked glycosylation (boxed, Fig. 2 ) that are conserved between the mouse and human FcyR se- Fig. 2 ) . The presumed cytoplasmic domain contains one potential site for N-linked glycosylation (nucleotides 764-772, Fig. 2 ), although it is unlikely to be used. The cytoplasmic domain is unusually long (76 amino acids), and no significant homology of this region to cytoplasmic domains of other receptors was detected .
Human FcyR cDNA Clones Represent a Novel FcyR mRNA Structure . Three distinct mouse Fc[y2b/y l ]R cDNA clones have been described (26) , designated a, #1, and #2. These cDNAs share identical or nearly (95%) identical sequences in their extracellular domains, but show marked differences elsewhere. Both FcyR# cDNAs are identical except for a 46 amino acid in-frame insertion in the predicted cytoplasmic tail of FcyR#l . In contrast, the Fc7Ra cDNA contains a unique set of sequences comprising the 5'-and 3'-untranslated regions, signal sequence, transmembrane domain, and cytoplasmic domain.
We compared the deduced amino acid sequence of the human FcyR with the available mouse Fc-yR sequences (Fig. 4, a and b) . Overall homology between the human and mouse extracellular domains is 61 % at the amino acid sequence level (75% nucleotide sequence homology). However, the signal sequence of human Fc-yR shares substantial homology (60%) only with mouse Fc7Ra; only 23% homology exists between the human and FcyR# signal sequences (Fig. 4b) . Conversely, the putative transmembrane domain shares^-50% amino acid homology with the corresponding region of the mouse FcyR# cDNA clones, but has virtually no similarity to Fc7Ra. The 76 amino acid cytoplasmic domain of the human protein is unrelated to any of the mouse cDNAs. The amino acid sequence comparisons summarized in Table I show that the sequence of the human Fc-yR cDNA consists of segments closely related to both the murine a and # cDNAs, as well as a unique cytoplasmic domain.
The Human Fc-yR cDNA Clone Hybridizes to Two Distinct mRNA Species in Human FcyR-expressing Cell Lines. Poly(A)+ RNA from several human cell lines was subjected to electrophoresis on a formaldehyde-agarose gel and examined by RNA blot hybridization with the human Fc-yR cDNA insert as a probe. The cDNA insert was isolated from pcD as an Xho I fragment (27) . Fig. 5 a shows that, in addition to a 1 .6-kb mRNA corresponding in size to clone 16 .2, a 2 .5-kb species was also detected in the U937 and HL60 cell lines. The same pattern was detected in RNA isolated from human peripheral blood mononuclear cells (data not shown) . No corresponding 2 .5-kb mRNA was detected by crosshybridization to P388D1 (mouse macrophage) RNA, although the 1 .6-kb species is seen (25, 26) . RNA from an FcyR -B-lymphoblastoid cell line (RPMI8866, reference 36) and a human T cell hybridoma (166A2, reference 37) did not hybridize to the Fc7R probe. The 1 .6-kb species and a trace of the 2.5-kb mRNA are also expressed by the FcyR-bearing B-lymphoblastoid cell line Daudi ( Fig.  5a ; reference 36). The relative intensities of the 1 .6-kb bands in U937 and Daudi RNAs suggest that this mRNA is more abundant in Daudi cells than in U937 .
The Fc-yR cDNA was also used as a probe of restriction digests of human placental DNA. The probe hybridizes to several both weak and intense bands (Fig . 6a) . These receptors exhibit specificity for IgG because binding of human IgA to the transfected cells was not detected (Fig . 6 b) . Mouse Ltk-cells subjected to a mock transfection procedure were unable to bind either IgG or IgA (Fig . 6,c and d) . Identical results were obtained with cDNA clones 16 .1 and 17 .1 (data not shown) .
Cells transfected with the FcyR cDNA clone were next tested for reactivity with several anti-human FcyR mAbs . No staining of transfected cells was observed with the anti-Fc7Rlo mAbs 3G8 (19) and Leu-11b (22) (data not shown), or the anti-FcTRI antibody 32 (Fig . 6e, reference 18) . However, the anti-FcyRII antibody IV .3 (16) specifically stained Ltk-cells transfected with the FcyR cDNA clone (Fig . 6, f and g ) . All mAbs were obtained from culture supernatants and were thus devoid of additional mouse IgG present in ascites STUART ET AL. Furthermore, it has thus far proved difficult to detect proteins corresponding to either FcyRa or FcyR,l31 in mouse macrophage and lymphocyte cell lines (Koch, T., and I Mellman, unpublished data) . To establish that clone 16.2 encodes an FcyR actually expressed by human cells, we tested human monocyte (U937) and FcyR+ B-lymphoblastoid (Daudi) cell lines for expression of FcyR related to this cDNA clone using antipeptide antibodies.
Two synthetic peptides were prepared, an 8-mer and 10-mer (broken overlines, Fig . 2 ). These peptides corresponded to regions of the FcyRII sequence likely to be present on the B iB-strands stabilized by the intrachain disulfides in Ig-like domains (32, 38) , and were selected with the aid of the program PEP (Intelligenetics, Inc .) The unconjugated peptides were used first for production of mouse mAbs using a modified procedure for in vitro immunization (Vaux, D. J. T., and I. Mellman, manuscript in preparation) . Since this procedure yields only antibodies of the IgM class, the resulting antipeptide antibodies were not likely to bind nonspecifically to FcyR. Supernatants harvested after the initial 4-d immunization and from several IgM-secreting hybridoma cell lines were used to stain receptor-positive and receptor-negative cells by indirect immunofluorescence . As shown by flow cytometry in Fig . 7 , specific staining of U937 cells was observed with any of several mAbs to the octapeptide (SP75 .3C5). No staining was observed using an irrelevant monoclonal IgM specific for a viral glycoprotein (F1 .2F7 ; Fig . 7a ). The anti-FcyR peptide antibodies failed to stain HeLa and HepG2 cells, both FcyR-negative human cell lines (data not shown) . Interestingly, the antipeptide antibodies also failed to stain Daudi cells appreciably (Fig. 7 b) , although these cells express a 1 .6-kb mRNA homologous to the FcyRII probe (Fig. 5a) . Similar results were obtained using a conventional rabbit polyclonal antiserum produced by injection of the unconjugated octapeptide directly into the popliteal lymph nodes . The antipeptide antibody SP75.3C5 also stained Ltkand Chinese hamster ovary cells transfected with the FcyR11 cDNA (data not shown) . These results demonstrate that cDNA clone 16.2 encodes a functional FcyR expressed on the surface of the U937 monocyte cell line.
U937 and Daudi cells were also analyzed for binding to aggregated IgG and anti-FcyRII antibody IV.3. Fig . 8 shows that U937 was stained with both IgG and IV.3. Daudi cells stained to a comparable extent with IgG, but only slight staining with IV.3 was detected, suggesting that the FcyRII expressed by these two cell lines are related (16 ; Fig . 5a ), but not identical (Figs. 7 and 8 ).
Discussion
We have cloned and determined the molecular structure of a human monocyte Fc receptor for IgG . Transfection of the cloned cDNA in mouse Ltk-cells results in expression of a surface receptor, specific for human IgG, which is recognized by the anti-FcyRII mAb IV. Our results demonstrate this conclusion at the molecular level.
The lack of reactivity of the cloned, expressed FcyRII with mAbs specific for the FcyRI and FcyRlo classes of human FcyR clearly distinguishes FcyRII from the latter two FcyR . However, it is still possible that this molecule may be structurally related to FcyRI and FcyRlo. The human FcyRII cDNA probe does detect a mRNA species in U937 that is larger (2.5 kb ; Fig. 5 The possibility of multiple gene segments related to FcyRII is also suggested by genomic blot analysis (Fig. 5) . With any of the restriction enzymes used, multiple large bands hybridizing to the FcyRII probe are detected. Because humans are not an inbred species, it is difficult to interpret these observations definitively . However, the data suggest that either the genomic FcyR gene(s) may exhibit restriction site polymorphism, the FcyR genomic gene(s) contain several large intervening sequences, or that the FcyR cDNA is homologous to a small multigene family comprising several members .
Our expression and genomic blot data suggest two possible explanations for a reported polymorphism in human monocyte FcyRII (39) . Monocytes of a large proportion of Caucasians support proliferation of human T cells mediated by the anti-T3 mAb Leu-4 (IgGI), while those of a majority of Asians do so only poorly . Anderson et al. (39) have demonstrated an association of distinct isoelectric focusing patterns of FcyRII with these "responder/nonresponder" phenotypes, and suggested that human FcyRII is encoded by a single gene with two allelic variants . This explanation may be correct if there are several large introns in the genomic FcyRII gene, or if there is restriction site polymorphism associated with the phenotypic polymorphism . Alternatively, the observed polymorphism could be explained by a difference in control of cell-type specificity of expression of individual members of an FcyRII gene family . In this light, we note again that FcyRII expressed on a B cell line is antigenically distinct from monocyte FcyRII (Figs. 7 and 8) , and supports Leu-4-mediated T cell proliferation only poorly (16) . We thus speculate that nonresponder individuals might express an FcyRII on their monocytes that is restricted to other cell types in responders .
The FcyRII cDNA clone has a signal sequence related to the mouse FcyRa cDNA, a putative transmembrane region homologous to the mouse Fc"YRO cDNA, and an extracellular domain closely related to both types of mouse FcyR (25, 26) . Thus, it is apparent that in human FcyR-expressing cells, a single FcyR protein may contain sequences related to both the a and a cDNAs of the mouse.
These findings indicate that the a-and ,B-specific gene segments are not uniquely associated with a particular gene segment encoding the extracellular domain of FcyR.
The FcyRII represented by clone 16.2 contains a unique, rather long cytoplasmic domain, which is unrelated to the mouse FcyR cytoplasmic domains or to those of other known receptor molecules . This observed heterogeneity of FcyR cytoplasmic domains remains unexplained. When such comparisons are made, it is unusual for interspecies homologues of cell surface molecules to diverge to a greater extent in their cytoplasmic domains than in their extracellular domains . The lack of similarity among FcyR cytoplasmic domains is particularly interesting in this case, since one can presume that the homologous FcyR should perform very similar functions in mouse and human macrophages, respectively . Either these functions do not require a particular primary structure for the cytoplasmic domain, or there remain several other members of an FcyR gene family yet to be isolated. It is possible that further study of ligand-dependent effector functions of FcyR such as endocytosis, antibody-dependent cellular cytotoxicity, superoxide production, and formation of bioactive lipids will clarify this issue and suggest functional roles for the various cytoplasmic domains of FcyR.
Like its murine counterparts, human FcyRII exhibits homology to proteins encoded by members of the Ig gene superfamily (poly-IgA/IgM receptor, MHC class II antigen, N-CAM) . We have also found a significant homology to a portion of the human CSF-1 receptor. The extracellular domains of both mouse and human FcyR have a characteristic structural feature : there are only 42-44 amino acid residues between cysteines, while Ig, poly-IgR, and MHC antigens have at least 80 residues between cysteines that form disulfide linkages . The truncated domains appear to lack at least two of the ,B-strands typically found in Ig-like domains (31) . In this respect, FcyR is closely related to N-CAM; the CSF-1 receptor also exhibits truncated Ig-like domains and is likewise related to human and mouse FcyR.
Anti-FcyRII peptide antibodies generated as described here may be very useful reagents for the study of FcyRII expression . They are the first amino acid sequence-specific antibodies produced against any human FcyR; that they are of the IgM class renders further manipulation (i.e., isolation of Fab fragments) unecessary . The FcyRII cDNA clone and its complementary antipeptide antibodies should make possible a thorough study of the expression of FcyRII on human hematopoietic cells and of its relationship to other classes of human FcyR.
